{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:35:48Z","timestamp":1777840548234,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"crossref","award":["01ET0717"],"award-info":[{"award-number":["01ET0717"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"crossref","award":["01GY1320A"],"award-info":[{"award-number":["01GY1320A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Saarland Ministry for Social Affairs, Health, Women, and Family Affairs"},{"name":"Physician-Scientist Programme of Heidelberg University, Faculty of Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To compare the prevalence of potentially inappropriate non-steroidal anti-inflammatory drugs (NSAIDs) among NSAIDs users defined with frequently used potentially inappropriate medication (PIM) lists and to identify the determinants of their use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Setting<\/jats:title><jats:p>Cross-sectional survey among community-dwelling older adults from Germany.<\/jats:p><\/jats:sec><jats:sec><jats:title>Subjects<\/jats:title><jats:p>N\u2009=\u2009284 NSAIDs users aged 65\u201389\u2009years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All currently regularly or as-needed used drugs were recorded during a home visit. Multivariate logistic regression models were applied to assess the potential determinants of potentially inappropriate NSAIDs use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Prevalence of potentially inappropriate NSAIDs use was 54.2%, 45.4%, 29.9%, 20.4%, and 3.5% when applying the STOPP, 2019 Beers, EU(7)-PIM, FORTA, and PRISCUS list, respectively. No study participant was identified as a potentially inappropriate NSAIDs user by all five lists simultaneously. The majority (68%) were identified only by one or two lists. Merely the STOPP and Beers criteria had a moderate inter-instrument agreement. Lower pain severity, gout, peptic ulcer (PU), cardiovascular disease (CVD), and chronic kidney disease (CKD) were statistically significantly associated with potentially inappropriate NSAIDs use defined by the STOPP criteria and the latter three conditions also with the 2019 Beers criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The STOPP and Beers criteria may be superior to the other lists because they more frequently identify potentially inappropriate NSAIDs use in conditions implying a high risk for NSAIDs' adverse events (i.e., PUD, CKD and CVD). We developed a harmonized, country-independent PIM list for NSAIDs with the same advantages as observed for the STOOP and 2019 Beers criteria and recommended its use.<\/jats:p><\/jats:sec>","DOI":"10.1093\/pm\/pnaa480","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T12:21:43Z","timestamp":1609244503000},"page":"1962-1969","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of Five Lists to Identify Potentially Inappropriate Use of Non-Steroidal Anti-Inflammatory Drugs in Older Adults"],"prefix":"10.1093","volume":"22","author":[{"given":"Thi Ngoc Mai","family":"Nguyen","sequence":"first","affiliation":[{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Network Aging Research, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana Clarissa","family":"Laetsch","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ju","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Network Aging Research, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Holleczek","sequence":"additional","affiliation":[{"name":"Saarland Cancer Registry, Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas D","family":"Meid","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Network Aging Research, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Sch\u00f6ttker","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Network Aging Research, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"issue":"4","key":"2021090908595088500_pnaa480-B1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur J Pain"},{"issue":"9","key":"2021090908595088500_pnaa480-B2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2165\/00002512-200320090-00006","article-title":"NSAID and aspirin use by the elderly in general practice: Effect on gastrointestinal symptoms and therapies","volume":"20","author":"Pilotto","year":"2003","journal-title":"Drugs Aging"},{"issue":"8","key":"2021090908595088500_pnaa480-B3","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","article-title":"Pharmacological management of persistent pain in older persons","volume":"57","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"2021090908595088500_pnaa480-B4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","article-title":"A turbulent decade for NSAIDs: Update on current concepts of classification, epidemiology, comparative efficacy, and toxicity","volume":"32","author":"Conaghan","year":"2012","journal-title":"Rheumatol Int"},{"key":"2021090908595088500_pnaa480-B5","doi-asserted-by":"crossref","first-page":"204209861982943","DOI":"10.1177\/2042098619829431","article-title":"Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences","volume":"10","author":"Curtin","year":"2019","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"2021090908595088500_pnaa480-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-013-1575-8","article-title":"Inappropriate prescribing: A systematic overview of published assessment tools","volume":"70","author":"Kaufmann","year":"2014","journal-title":"Eur J Clin Pharm"},{"issue":"2","key":"2021090908595088500_pnaa480-B7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: Version 2","volume":"44","author":"O\u2019Mahony","year":"2014","journal-title":"Age Ageing"},{"issue":"4","key":"2021090908595088500_pnaa480-B8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"2021090908595088500_pnaa480-B9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40266-019-00669-6","article-title":"The FORTA (Fit fOR The Aged) list 2018: third version of a validated clinical tool for improved drug treatment in older people","volume":"36","author":"Pazan","year":"2019","journal-title":"Drugs Aging"},{"issue":"7","key":"2021090908595088500_pnaa480-B10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU(7)-PIM list: A list of potentially inappropriate medications for older people consented by experts from seven European countries","volume":"71","author":"Renom-Guiteras","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"31-32","key":"2021090908595088500_pnaa480-B11","first-page":"543","article-title":"Potentially inappropriate medications in the elderly: The PRISCUS list","volume":"107","author":"Holt","year":"2010","journal-title":"Deutsch Arztebl Int"},{"issue":"4","key":"2021090908595088500_pnaa480-B12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3945\/ajcn.112.047712","article-title":"Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study","volume":"97","author":"Schottker","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2021090908595088500_pnaa480-B13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/fampra\/16.3.278","article-title":"Brown bag\u2019 medication reviews as a means of optimizing patients\u2019 use of medication and of identifying potential clinical problems","volume":"16","author":"Nathan","year":"1999","journal-title":"Fam Pract"},{"issue":"8","key":"2021090908595088500_pnaa480-B14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00228-017-2266-7","article-title":"Polypharmacy and mortality: New insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication","volume":"73","author":"Schottker","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2021090908595088500_pnaa480-B15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"JVENN: An interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"2021090908595088500_pnaa480-B16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-199600525-00004","article-title":"The mechanisms of action of NSAIDs in analgesia","volume":"52 Suppl 5","author":"Cashman","year":"1996","journal-title":"Drugs"},{"issue":"3","key":"2021090908595088500_pnaa480-B17","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of non-steroidal anti-inflammatory drugs","volume":"104","author":"Vane","year":"1998","journal-title":"Am J Med"},{"key":"2021090908595088500_pnaa480-B18","author":"Hawboldt","year":"2008"},{"issue":"9","key":"2021090908595088500_pnaa480-B19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1503\/cmaj.1041606","article-title":"Rofecoxib (Vioxx) voluntarily withdrawn from market","volume":"171","author":"Sibbald","year":"2004","journal-title":"CMAJ"},{"issue":"11","key":"2021090908595088500_pnaa480-B20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with non-steroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"2021090908595088500_pnaa480-B21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/j.gastro.2007.06.058","article-title":"Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs","volume":"133","author":"Ray","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"2021090908595088500_pnaa480-B22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnaa480\/36652678\/pnaa480.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/22\/9\/1962\/40330748\/pnaa480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/22\/9\/1962\/40330748\/pnaa480.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T12:13:35Z","timestamp":1697458415000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/22\/9\/1962\/6179646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,3,22]]},"published-print":{"date-parts":[[2021,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnaa480","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,3,22]]}}}